Combination of oncolytic virus with immune checkpoint modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10765710
APP PUB NO 20170143780A1
SERIAL NO

15325576

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulator(s) for use for the treatment of a proliferative disease such as cancer. It also relates to a kit comprising an oncolytic virus and one or more immune checkpoint modulator(s) in separate containers. It also concerns a pharmaceutical composition comprising effective amount of an oncolytic virus and one or more immune checkpoint modulator(s).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INSTITUT GUSTAVE-ROUSSY; TRANSGENE SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fend, Laetitia Le Kremlin-bicetre, FR 2 25
Preville, Xavier Saint Louis, FR 6 32
Zitvogel, Laurence Paris, FR 31 197

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 8, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 8, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00